LMR Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-42,400	Closed	-$689K	–	1287
2022 Q1	$689K	Sell	42,400 -70,000	-62%	-$1.14M	0.01%	921
2021 Q4	$1.56M	Buy	112,400 +63,400	+129%	+$878K	0.02%	544
2021 Q3	$704K	Buy	+49,000	New	+$704K	0.01%	716